David Guzo

Array ( [id] => 5631616 [patent_doc_number] => 20060148086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Vault and vault-like carrier molecules' [patent_app_type] => utility [patent_app_number] => 10/547530 [patent_app_country] => US [patent_app_date] => 2004-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10338 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148086.pdf [firstpage_image] =>[orig_patent_app_number] => 10547530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083091 [patent_doc_number] => 20050048471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Albumin derivatives with therapeutic functions' [patent_app_type] => utility [patent_app_number] => 10/794774 [patent_app_country] => US [patent_app_date] => 2004-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 15573 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048471.pdf [firstpage_image] =>[orig_patent_app_number] => 10794774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7423016 [patent_doc_number] => 20040229361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Use of human serum resistant vector particles and cell lines for human gene therapy' [patent_app_type] => new [patent_app_number] => 10/791467 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6924 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229361.pdf [firstpage_image] =>[orig_patent_app_number] => 10791467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7425370 [patent_doc_number] => 20040161421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Intramyocardial injection of autologous bone marrow' [patent_app_type] => new [patent_app_number] => 10/776545 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8974 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20040161421.pdf [firstpage_image] =>[orig_patent_app_number] => 10776545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7317757 [patent_doc_number] => 20040224410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Non-lytic baculovirus' [patent_app_type] => new [patent_app_number] => 10/775050 [patent_app_country] => US [patent_app_date] => 2004-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7928 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224410.pdf [firstpage_image] =>[orig_patent_app_number] => 10775050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7428703 [patent_doc_number] => 20040266006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Adenoviral vectors having a protein IX deletion' [patent_app_type] => new [patent_app_number] => 10/766363 [patent_app_country] => US [patent_app_date] => 2004-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 16741 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266006.pdf [firstpage_image] =>[orig_patent_app_number] => 10766363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7233474 [patent_doc_number] => 20040157213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Fungal reverse transcriptases with enhanced capabilities' [patent_app_type] => new [patent_app_number] => 10/765456 [patent_app_country] => US [patent_app_date] => 2004-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12495 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157213.pdf [firstpage_image] =>[orig_patent_app_number] => 10765456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 393843 [patent_doc_number] => 07297536 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-20 [patent_title] => 'Inducible protein expression system' [patent_app_type] => utility [patent_app_number] => 10/763976 [patent_app_country] => US [patent_app_date] => 2004-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 22 [patent_no_of_words] => 9516 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/297/07297536.pdf [firstpage_image] =>[orig_patent_app_number] => 10763976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 933981 [patent_doc_number] => 06977176 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-20 [patent_title] => 'Plasmid maintenance system for antigen delivery' [patent_app_type] => utility [patent_app_number] => 10/750976 [patent_app_country] => US [patent_app_date] => 2004-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 32 [patent_no_of_words] => 30595 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 231 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/977/06977176.pdf [firstpage_image] =>[orig_patent_app_number] => 10750976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7425332 [patent_doc_number] => 20040161420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Plasmid maintenance system for antigen delivery' [patent_app_type] => new [patent_app_number] => 10/750965 [patent_app_country] => US [patent_app_date] => 2004-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 31715 [patent_no_of_claims] => 155 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20040161420.pdf [firstpage_image] =>[orig_patent_app_number] => 10750965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7025435 [patent_doc_number] => 20050019829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Protein/solubility folding assessed by structural complementation' [patent_app_type] => utility [patent_app_number] => 10/748720 [patent_app_country] => US [patent_app_date] => 2003-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 32054 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20050019829.pdf [firstpage_image] =>[orig_patent_app_number] => 10748720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 567585 [patent_doc_number] => 07465787 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-16 [patent_title] => 'Yeast cell surface display of proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/738454 [patent_app_country] => US [patent_app_date] => 2003-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 36 [patent_no_of_words] => 22909 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/465/07465787.pdf [firstpage_image] =>[orig_patent_app_number] => 10738454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 816982 [patent_doc_number] => 07410790 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-12 [patent_title] => 'Method for producing γ-glutamylcysteine' [patent_app_type] => utility [patent_app_number] => 10/732523 [patent_app_country] => US [patent_app_date] => 2003-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 8149 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/410/07410790.pdf [firstpage_image] =>[orig_patent_app_number] => 10732523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 626956 [patent_doc_number] => 07135339 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-14 [patent_title] => 'Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV)' [patent_app_type] => utility [patent_app_number] => 10/718262 [patent_app_country] => US [patent_app_date] => 2003-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 18988 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/135/07135339.pdf [firstpage_image] =>[orig_patent_app_number] => 10718262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7063709 [patent_doc_number] => 20050005310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Expression vectors and methods' [patent_app_type] => utility [patent_app_number] => 10/714000 [patent_app_country] => US [patent_app_date] => 2003-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 23993 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20050005310.pdf [firstpage_image] =>[orig_patent_app_number] => 10714000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 524441 [patent_doc_number] => 07183079 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-27 [patent_title] => 'Compositions and methods for enhancing disease resistance in fish' [patent_app_type] => utility [patent_app_number] => 10/702395 [patent_app_country] => US [patent_app_date] => 2003-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16145 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/183/07183079.pdf [firstpage_image] =>[orig_patent_app_number] => 10702395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7150943 [patent_doc_number] => 20040171569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Artificial chromosome constructs containing foreign nucleic acid sequences' [patent_app_type] => new [patent_app_number] => 10/701152 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8407 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171569.pdf [firstpage_image] =>[orig_patent_app_number] => 10701152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7677760 [patent_doc_number] => 20040152066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Freeze-tolerant eukaryotic cells' [patent_app_type] => new [patent_app_number] => 10/476728 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15110 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152066.pdf [firstpage_image] =>[orig_patent_app_number] => 10476728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 860171 [patent_doc_number] => 07371570 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-13 [patent_title] => 'Cell-specific adenovirus vector comprising EBV-specific promoter' [patent_app_type] => utility [patent_app_number] => 10/698160 [patent_app_country] => US [patent_app_date] => 2003-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13676 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/371/07371570.pdf [firstpage_image] =>[orig_patent_app_number] => 10698160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7269414 [patent_doc_number] => 20040057932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same' [patent_app_type] => new [patent_app_number] => 10/696282 [patent_app_country] => US [patent_app_date] => 2003-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11499 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20040057932.pdf [firstpage_image] =>[orig_patent_app_number] => 10696282 [rel_patent_id] =>[rel_patent_doc_number] =>)